Successful use of emicizumab in a patient with refractory acquired hemophilia A and acute coronary syndrome requiring percutaneous coronary intervention.

Dane, Kathryn E; Lindsley, John P; Streiff, Michael B; Moliterno, Alison R; Khalid, Mian K; Shanbhag, Satish

Dane, Kathryn E; Lindsley, John P; Streiff, Michael B; Moliterno, Alison R; Khalid, Mian K; Shanbhag, Satish.

Afiliação

Dane KE; The Johns Hopkins Hospital Department of Pharmacy Baltimore Maryland.
Lindsley JP; The Johns Hopkins Hospital Department of Pharmacy Baltimore Maryland.
Streiff MB; Division of Hematology Department of Medicine Johns Hopkins University School of Medicine Baltimore Maryland.
Moliterno AR; Division of Hematology Department of Medicine Johns Hopkins University School of Medicine Baltimore Maryland.
Khalid MK; Division of Medical Oncology and Hematology Kaiser Permanente Baltimore Maryland.
Shanbhag S; Division of Hematology Department of Medicine Johns Hopkins University School of Medicine Baltimore Maryland.

Res Pract Thromb Haemost ; 3(3): 420-423, 2019 Jul.

Article em En | MEDLINE | ID: mdl-31294330

Palavras-chave

acute coronary syndrome; blood coagulation factor inhibitors; coronary artery disease; hemophilia A; platelet aggregation inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article